BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17332926)

  • 1. The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.
    Matsumoto K; Szajek L; Krishna MC; Cook JA; Seidel J; Grimes K; Carson J; Sowers AL; English S; Green MV; Bacharach SL; Eckelman WC; Mitchell JB
    Int J Oncol; 2007 Apr; 30(4):873-81. PubMed ID: 17332926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
    Lewis JS; McCarthy DW; McCarthy TJ; Fujibayashi Y; Welch MJ
    J Nucl Med; 1999 Jan; 40(1):177-83. PubMed ID: 9935074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
    Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
    J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2.
    Li F; Jørgensen JT; Forman J; Hansen AE; Kjaer A
    J Nucl Med; 2016 Mar; 57(3):437-43. PubMed ID: 26585061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
    Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
    Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
    Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
    Bonnitcha PD; Bayly SR; Theobald MB; Betts HM; Lewis JS; Dilworth JR
    J Inorg Biochem; 2010 Feb; 104(2):126-35. PubMed ID: 19932509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
    Dence CS; Ponde DE; Welch MJ; Lewis JS
    Nucl Med Biol; 2008 Aug; 35(6):713-20. PubMed ID: 18678357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review.
    Bourgeois M; Rajerison H; Guerard F; Mougin-Degraef M; Barbet J; Michel N; Cherel M; Faivre-Chauvet A
    Nucl Med Rev Cent East Eur; 2011; 14(2):90-5. PubMed ID: 22219149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
    Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
    Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
    Chao KS; Bosch WR; Mutic S; Lewis JS; Dehdashti F; Mintun MA; Dempsey JF; Perez CA; Purdy JA; Welch MJ
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1171-82. PubMed ID: 11240261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.
    Bowen SR; van der Kogel AJ; Nordsmark M; Bentzen SM; Jeraj R
    Nucl Med Biol; 2011 Aug; 38(6):771-80. PubMed ID: 21843774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.
    Hueting R; Kersemans V; Cornelissen B; Tredwell M; Hussien K; Christlieb M; Gee AD; Passchier J; Smart SC; Dilworth JR; Gouverneur V; Muschel RJ
    J Nucl Med; 2014 Jan; 55(1):128-34. PubMed ID: 24337603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.
    Carlin S; Zhang H; Reese M; Ramos NN; Chen Q; Ricketts SA
    J Nucl Med; 2014 Mar; 55(3):515-21. PubMed ID: 24491409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paired 18F-Fluorodeoxyglucose (18F-FDG), and 64Cu-Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) (64Cu-ATSM) PET Scans in Dogs with Spontaneous Tumors and Evaluation for Hypoxia-Directed Therapy.
    Maitz CA; Tate D; Bechtel S; Lunceford J; Henry C; Flesner B; Collins A; Varterasian M; Tung D; Zhang L; Saha S; Bryan JN
    Radiat Res; 2022 Mar; 197(3):253-260. PubMed ID: 34855934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.
    Ballegeer EA; Madrill NJ; Berger KL; Agnew DW; McNiel EA
    BMC Cancer; 2013 Apr; 13():218. PubMed ID: 23631652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model.
    Nie X; Laforest R; Elvington A; Randolph GJ; Zheng J; Voller T; Abendschein DR; Lapi SE; Woodard PK
    J Nucl Med; 2016 Dec; 57(12):2006-2011. PubMed ID: 27390157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.
    Kersemans V; Cornelissen B; Hueting R; Tredwell M; Hussien K; Allen PD; Falzone N; Hill SA; Dilworth JR; Gouverneur V; Muschel RJ; Smart SC
    PLoS One; 2011; 6(11):e25911. PubMed ID: 22102855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.